Progress in the study on animal model of diabetic nephropathy

Chinese Pharmacological Bulletin

Volumn 24, Issue 7, 2008, Pages 845-848

  Zhang, Hao Jun ^a   Zhao, Jing Bo ^b   Li, Ping ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Animal model; Diabetic mephropathy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; C57BL MOUSE; DIABETIC NEPHROPATHY; DISEASE MODEL; EXPERIMENTAL ANIMAL; INTERMETHOD COMPARISON; NONHUMAN; TRANSGENIC ANIMAL; WISTAR RAT;

EID: 56049118700     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wang Z J, Liu S. Progress in the study on of diabetic nephropathy [J]. Int J Urol Nephrol,2006,26(5):693-6.
2. Li W, Zhang H, Yin S L, Zhu X. Optimal dosage of streptozotocin for inducing diabetic nephropathy in model rats[J]. Acta Acad Med Xuzhou, 2006,26:52-5.
3. 1 in the kidney of streptozocin-induced diabetic nephropathy rats[J]. J China-Japan Friendship Hospit,2003,17 (5):299-300.
4. Liu W H, Yang B, Tao S, et al. Protective effects of Jiaotai pill complex prescription on renal injury in diabetic rats[J]. Chin Pharmacol Bull,2007,23(4):559-60.
5. Feng J C, Ning Q. Experimental study of treating diabetic nephropathy with Shishitangshen capsule[J]. Chin J Exp Tradit Med Formul, 2000,6(6):32-6.
6. Jiang H J, Liu J S, Zhu Z H, et al. The effect and significance of candesartan on the SGK1 expression in murine diabetic nephropathy kidney[J]. Chin Pharmacol Bull,2006,22(5):547-51.
7. Hamada Y, Fukagawa M. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin - induced diabetic nephropathy [J]. Kobe J Med Sci, 2007;53(1-2):53-61.
8. Ye S D, Chen Y, Wang Y X, et al. Renoprotection of diabetic rats with losartan[J]. Chin J New Drugs,2007,16(8):610-3.
9. Lei Z X, Luo R, Dong X L, Zhong X Y. Establishment of STZ-induced diabetic nephropathic rat model[J]. Acta Lab Anim Sci Sin, 2005, 13(3):163-6.
10. Li J L, Qiao W J, Zheng S Q, Zheng X M. Compare the difference between the two diabetic nephropathy models on Rats[J]. Liaoning J Tradit Chin Med,2003,30:877-8.
11. Cha D Q, Wu X Y, Xu L F, Jia R H. Comparison of two animal models of type 2 diabetic nephropathy[J]. Med J Wuhan Univ, 2006,27:253-5.
12. Guo X H, Liu Z H, Li H, Li L S. Type 2 diabetes mellitus induced by diets and its features of renal involvement in rat[J]. Chin J Diabet, 2002,10(5):290-4.
13. Sugano M, Yamato H, Hayashi T, et al. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy[J]. Nutr Metab Cardiovasc Dis,2006,16(7):477-84.
14. Jeansson M, Granqvist A B, Nystrøm J S, Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice[J]. Diabetologia,2006,49(9):2200-9.
15. Feld L G, Cachero S, Ellis E N, et al. Resistance to glomerular injury in the diabetic biobreeding rat[J]. Exp Physiol,1995,80:991-1000.
16. Proctor G, Jiang T, Iwahashi M, et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation,and fibrosis in Akita and OVE26 mice with type 1 diabetes[J]. Diabetes,2006,55:2502-9.
17. Sharma K, McCue P, Dunn S R. Diabetic kidney disease in the db/db mouse[J]. Am J Physiol Renal Physiol,2003,284:F1138-44.
18. Liu Y J. Spontaneous type 2 diabetic animal model - OLETF rat [J]. Foreign Med Sci Sect Endocrinol,1999,19:26-9.
19. Janssen U, Vassiliadou A, Riley S G, et al. The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat[J]. J Nephrol,2004,17:769-73.
20. Nobrega M A, Fleming S, Roman R J, et al. Initial characterization of a rat model of diabetic nephropathy[J]. Diabetes,2004,53:735-42.
21. Schafer S, Linz W, Bube A, et al. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats[J]. Cardiovasc Res, 2003,60:447-54.
22. Gassler N, Elger M, Kranzlin B, et al. Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat[J]. Kidney Int,2001,60:106-16.
23. Chen L M, Li X W, Huang L W, et al. The early pathological changes of KKay mice with type 2 diabetes[J]. Acta Acad Med Sin. 2002,24:71-5.
24. Gross M L, Ritz E, Schoof A, et al. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes[J]. Lab Invest,2004, 84:452-64.
25. Kelly D J, Wilkinson-Berka J L, Allen T J, et al. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2) 27 rat (TGR)[J]. Kidney Int,1998,54:343-52.
26. Inada A, Nagai K, Arai H, et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy[J]. Am J Pathol, 2005,167:327-36.
27. Zheng S, Noonan W T, Metreveli N S, et al. Development of late-stage diabetic nephropathy in OVE26 diabetic mice[J]. Diabetes, 2004,53:3248-57.
28. Krag S, Nyengaard J R, Wogensen L. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production[J]. Nephrol Dial Transplant. 2007,22(9):2485-96.
29. Yamamoto Y, Kato I, Doi T, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice[J]. J Clin Invest,2001,108:261-8.
30. Zhao H J, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice [J]. J Am Soc Nephrol,2006,17:2664-9.
31. Inagi R, Yamamoto Y, Nangaku M, et al. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice [J]. Diabetes,2006, 55:356-66.